Back to Trials
NCT06117930RecruitingAccepts Healthy Volunteers

Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research

Mayo Clinic

Start Date

2/28/2024

Completion Date

12/13/2029

Summary

This study explores how microorganisms in the gut can affect the growth and progression of brain tumors.

Detailed Description

PRIMARY OBJECTIVES: I. To establish a Mayo Clinic Florida Brain Tumor-Gut Axis Human Biorepository by sequential collection of fecal, urine, blood, saliva, and/or tissue samples and clinical patient information. II. To use spatial transcriptome/proteomics/multi-omics coupled with microbiome data from various sources including brain tissue and stool samples to understand how microbiota could impact disease development, progression, and treatment response in patients with brain cancer. III. To study the effect of microbiome and potential relationships and/or microbiome reconstruction to impact patient's clinical outcomes including chemo, radiation, immunotherapy and/or cellular therapy. OUTLINE: This is an observational study. Participants undergo blood, tissue, saliva, urine and stool sample collection and complete questionnaires on study.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study. Exclusion Criteria: * Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.

Interventions

OTHER

Non-Interventional Study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Malignant Central Nervous System Neoplasm

Locations

Mayo Clinic in Florida

Jacksonville, Florida 32224-9980

United States